MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Evoke Pharma Company Profile (NASDAQ:EVOK)

Consensus Ratings for Evoke Pharma (NASDAQ:EVOK) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $19.14 (255.16% upside)

Analysts' Ratings History for Evoke Pharma (NASDAQ:EVOK)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Rodman & RenshawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2016Northland SecuritiesInitiated CoverageOutperform$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Ascendiant Capital MarketsBoost Price TargetBuy$11.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016Noble FinancialReiterated RatingBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2015HC WainwrightInitiated CoverageBuy$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Cantor FitzgeraldReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014MLV & Co.Boost Price TargetBuy$12.50 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha